Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Nuclear Science and Technology (3)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (26)
- Clean Energy (30)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (1)
- Fusion and Fission (2)
- Isotopes (6)
- Materials (51)
- Materials for Computing (10)
- National Security (21)
- Neutron Science (16)
- Quantum information Science (4)
- Supercomputing (33)
News Topics
- (-) Biomedical (2)
- (-) Cybersecurity (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (11)
- Bioenergy (1)
- Computer Science (2)
- Coronavirus (1)
- Decarbonization (1)
- Environment (1)
- Fusion (8)
- Isotopes (5)
- Materials Science (3)
- Molten Salt (4)
- Neutron Science (5)
- Nuclear Energy (36)
- Physics (2)
- Space Exploration (5)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
Two staff members at the Department of Energy’s Oak Ridge National Laboratory have received prestigious HENAAC and Luminary Awards from Great Minds in STEM, a nonprofit organization that focuses on promoting STEM careers in underserved
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.